Literature DB >> 7568077

Telomerase activity in normal and malignant hematopoietic cells.

D Broccoli1, J W Young, T de Lange.   

Abstract

Bone marrow and peripheral blood leukocytes from 19 leukemia patients were found to contain telomerase activity detectable by a PCR-based assay. Telomerase was also detectable in nonmalignant bone marrow and peripheral blood leukocytes from normal donors, including fractions enriched for granulocytes, T lymphocytes, and monocytes/B cells. Semiquantitative comparison revealed considerable overlap between telomerase activities in samples from normal subjects and leukemia patients, confounding evaluation of the role of telomerase in this disease. These data indicate that human telomerase is not restricted to immortal cells and suggest that the somatic expression of this enzyme may be more widespread than was previously inferred from the decline of human telomeres.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568077      PMCID: PMC40928          DOI: 10.1073/pnas.92.20.9082

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Sugar and disease.

Authors:  J Yudkin
Journal:  Nature       Date:  1972-09-22       Impact factor: 49.962

2.  Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes.

Authors:  C M Counter; F M Botelho; P Wang; C B Harley; S Bacchetti
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 3.  Activation of telomerase in a human tumor.

Authors:  T de Lange
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 4.  Mammalian telomere dynamics: healing, fragmentation shortening and stabilization.

Authors:  C W Greider
Journal:  Curr Opin Genet Dev       Date:  1994-04       Impact factor: 5.578

5.  Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n.

Authors:  F Ishikawa; M J Matunis; G Dreyfuss; T R Cech
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  Telomerase activity in human ovarian carcinoma.

Authors:  C M Counter; H W Hirte; S Bacchetti; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.

Authors:  H Vaziri; W Dragowska; R C Allsopp; T E Thomas; C B Harley; P M Lansdorp
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts.

Authors:  J W Shay; W E Wright; D Brasiskyte; B A Van der Haegen
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

9.  Telomerase activity in normal leukocytes and in hematologic malignancies.

Authors:  C M Counter; J Gupta; C B Harley; B Leber; S Bacchetti
Journal:  Blood       Date:  1995-05-01       Impact factor: 22.113

10.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

View more
  168 in total

1.  Functional requirement of p23 and Hsp90 in telomerase complexes.

Authors:  S E Holt; D L Aisner; J Baur; V M Tesmer; M Dy; M Ouellette; J B Trager; G B Morin; D O Toft; J W Shay; W E Wright; M A White
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

Review 2.  Crisis intervention: the role of telomerase.

Authors:  A J Lustig
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study.

Authors:  Jennifer Daubenmier; Jue Lin; Elizabeth Blackburn; Frederick M Hecht; Jean Kristeller; Nicole Maninger; Margaret Kuwata; Peter Bacchetti; Peter J Havel; Elissa Epel
Journal:  Psychoneuroendocrinology       Date:  2011-12-14       Impact factor: 4.905

Review 4.  How long should telomeres be?

Authors:  A Aviv; C B Harley
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 5.  The role of telomerase expression and telomere length maintenance in human and mouse.

Authors:  N P Weng; R J Hodes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

6.  Telomerase expression in uveal melanoma.

Authors:  B Heine; S E Coupland; S Kneiff; G Demel; N Bornfeld; M Hummel; H Stein
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

7.  Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation.

Authors:  C O'Flatharta; M Leader; E Kay; S R Flint; M Toner; W Robertson; M J E M F Mabruk
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

8.  Telomerase extracurricular activities.

Authors:  Sandy Chang; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

9.  Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.

Authors:  Christina Y Soohoo; Rong Shi; Tae Ho Lee; Pengyu Huang; Kun Ping Lu; Xiao Zhen Zhou
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

10.  Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle.

Authors:  Isabel Beerman; Jun Seita; Matthew A Inlay; Irving L Weissman; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2014-05-08       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.